AKT1 and neoplasm: Some other studies have also demonstrated that IGFBP-2 can be considered as a regulator of phosphatidylinositol 3-kinase (PI3K)/Akt/PTEN to promote tumor progression (19,21,28) and also as a p53 target (29).